CN1257550A - 子宫内膜癌的检测 - Google Patents

子宫内膜癌的检测 Download PDF

Info

Publication number
CN1257550A
CN1257550A CN98805312A CN98805312A CN1257550A CN 1257550 A CN1257550 A CN 1257550A CN 98805312 A CN98805312 A CN 98805312A CN 98805312 A CN98805312 A CN 98805312A CN 1257550 A CN1257550 A CN 1257550A
Authority
CN
China
Prior art keywords
mmp
level
uterine
determined
endometrial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN98805312A
Other languages
English (en)
Chinese (zh)
Inventor
亚历山大·罗帕塔
洛伊丝·A·萨拉蒙森
迈克尔·A·奎因
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pulis Henry Medical Research Institute
University of Melbourne
Original Assignee
Pulis Henry Medical Research Institute
University of Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pulis Henry Medical Research Institute, University of Melbourne filed Critical Pulis Henry Medical Research Institute
Publication of CN1257550A publication Critical patent/CN1257550A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G01N2333/96491—Metalloendopeptidases (3.4.24) with definite EC number
    • G01N2333/96494—Matrix metalloproteases, e. g. 3.4.24.7

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN98805312A 1997-03-20 1998-03-20 子宫内膜癌的检测 Pending CN1257550A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPO5736 1997-03-20
AUPO5736A AUPO573697A0 (en) 1997-03-20 1997-03-20 Diagnosis of endometrial cancer

Publications (1)

Publication Number Publication Date
CN1257550A true CN1257550A (zh) 2000-06-21

Family

ID=3800039

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98805312A Pending CN1257550A (zh) 1997-03-20 1998-03-20 子宫内膜癌的检测

Country Status (14)

Country Link
US (1) US6607894B1 (https=)
EP (1) EP0979304B1 (https=)
JP (2) JP4183757B2 (https=)
KR (1) KR20010006344A (https=)
CN (1) CN1257550A (https=)
AT (1) ATE331039T1 (https=)
AU (1) AUPO573697A0 (https=)
CA (1) CA2284099C (https=)
DE (1) DE69835010T2 (https=)
ES (1) ES2268767T3 (https=)
MY (1) MY119567A (https=)
NZ (1) NZ337868A (https=)
WO (1) WO1998042865A1 (https=)
ZA (1) ZA982403B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107532208A (zh) * 2015-02-06 2018-01-02 奎斯特诊断投资有限责任公司 用于测定子宫内膜癌预后的组合物和方法

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1066408A4 (en) * 1998-03-05 2002-09-25 Diadexus Inc A NEW METHOD FOR DETECTING AND DISPLAYING ENDOMETRIC AND UTERUS CANCER
AUPQ219799A0 (en) 1999-08-13 1999-09-02 R. Lurie Pty Ltd Apparatus for obtaining potological samples
US6906036B2 (en) 2001-08-16 2005-06-14 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US7186693B2 (en) 2001-08-16 2007-03-06 Kimberly - Clark Worldwide, Inc. Metalloproteinase inhibitors for wound healing
US7071164B2 (en) 2001-08-16 2006-07-04 Kimberly-Clark Worldwide, Inc. Anti-cancer and wound healing compounds
US7094754B2 (en) 2001-08-16 2006-08-22 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
DE10217677A1 (de) 2002-04-19 2003-11-06 Bayer Ag Verwendung von Aufhellern zur Herstellung von Streichmassen
US7148194B2 (en) 2002-12-30 2006-12-12 Kimberly-Clark Worldwide, Inc. Method to increase fibronectin
US7189700B2 (en) 2003-06-20 2007-03-13 Kimberly-Clark Worldwide, Inc. Anti-chrondrosarcoma compounds
US20050112622A1 (en) * 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
US20060003391A1 (en) * 2003-08-11 2006-01-05 Ring Brian Z Reagents and methods for use in cancer diagnosis, classification and therapy
ES2342394T3 (es) * 2004-07-23 2010-07-06 Centre De Recherche Public De La Sante Supervision de la insuficiencia cardiaca.
US20080131916A1 (en) * 2004-08-10 2008-06-05 Ring Brian Z Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy
MX2007009566A (es) * 2005-02-09 2009-02-16 Genentech Inc Inhibicion de la difusion de la her2 con antagonistas de la metaloproteasa de matriz.
US7504225B2 (en) * 2005-05-12 2009-03-17 Applied Genomics, Inc. Reagents and methods for use in cancer diagnosis, classification and therapy
RU2304782C1 (ru) * 2005-12-28 2007-08-20 Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М. Сеченова Способ прогнозирования рецидива эндометриоидной кисты яичника
ES2567079T3 (es) 2007-11-02 2016-04-19 Momenta Pharmaceuticals, Inc. Composiciones de polisacáridos que no son anticoagulantes
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8592393B2 (en) 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US20120183976A1 (en) * 2009-04-16 2012-07-19 He Zhou Methods of assessing activity of a polysaccharide composition
CA2767914C (en) * 2009-07-24 2020-02-25 Geadic Biotec, Aie. Markers for endometrial cancer
US9387256B2 (en) 2010-04-16 2016-07-12 Momenta Pharmaceuticals, Inc. Tissue targeting
RU2430371C1 (ru) * 2010-04-26 2011-09-27 Учреждение Российской академии наук Институт ядерной физики им. Г.И. Будкера Сибирского отделения РАН (ИЯФ СО РАН) Способ дифференциальной диагностики и прогноза миомы и рака эндометрия
WO2011159770A2 (en) 2010-06-17 2011-12-22 Momenta Pharmaceuticals, Inc. Methods and compositions for modulating hair growth
US8455624B2 (en) * 2011-06-03 2013-06-04 University Of South Alabama Methods and compositions for detecting endometrial or ovarian cancer
AU2012312071C1 (en) * 2011-09-22 2017-08-24 Memorial Sloan-Kettering Cancer Center Detecting ovarian cancer
HRP20181726T1 (hr) * 2012-01-31 2018-12-28 SPEISER, Paul Neinvazivno dijagnosticiranje raka
US10016449B2 (en) 2013-05-28 2018-07-10 Momenta Pharmaceuticals, Inc. Pharmaceutical compositions
US10564162B2 (en) * 2014-07-02 2020-02-18 Bionomics Limited Predictive biomarkers
WO2017190896A1 (en) * 2016-05-04 2017-11-09 Fundació Hospital Universitari Vall D'hebron - Institut De Recerca Mmp9 as marker of endometrial cancer
IN202021002695A (https=) 2020-01-21 2021-07-23
CN112961921B (zh) * 2021-03-26 2022-07-01 中国医学科学院北京协和医院 一种用于判断早期子宫内膜癌预后的制剂及复发风险模型

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5280106A (en) * 1988-05-20 1994-01-18 Liotta Lance A Matrix metalloproteinase peptides: role in diagnosis and therapy
US5324634A (en) 1992-03-31 1994-06-28 The Research Foundation Of State University Of New York Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer
WO1994005807A1 (en) * 1992-08-28 1994-03-17 Dickson Robert B Matrix-degrading metalloproteinase
AU6396494A (en) * 1992-11-16 1994-06-08 Cancer Research Fund Of Contra Costa Peptides and anti-sense peptides with broad neoplastic specificity

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107532208A (zh) * 2015-02-06 2018-01-02 奎斯特诊断投资有限责任公司 用于测定子宫内膜癌预后的组合物和方法
CN107532208B (zh) * 2015-02-06 2022-07-05 奎斯特诊断投资有限责任公司 用于测定子宫内膜癌预后的组合物和方法

Also Published As

Publication number Publication date
CA2284099A1 (en) 1998-10-01
JP4183757B2 (ja) 2008-11-19
JP2002501613A (ja) 2002-01-15
ATE331039T1 (de) 2006-07-15
US6607894B1 (en) 2003-08-19
CA2284099C (en) 2010-04-27
ZA982403B (en) 1998-10-21
DE69835010D1 (de) 2006-08-03
EP0979304A4 (en) 2003-06-11
EP0979304A1 (en) 2000-02-16
AUPO573697A0 (en) 1997-04-10
KR20010006344A (ko) 2001-01-26
NZ337868A (en) 2002-05-31
WO1998042865A1 (en) 1998-10-01
JP2007202556A (ja) 2007-08-16
ES2268767T3 (es) 2007-03-16
DE69835010T2 (de) 2007-06-06
EP0979304B1 (en) 2006-06-21
MY119567A (en) 2005-06-30

Similar Documents

Publication Publication Date Title
CN1257550A (zh) 子宫内膜癌的检测
Hagag et al. Role of ultrasound-guided fine-needle aspiration biopsy in evaluation of nonpalpable thyroid nodules
Dillon et al. Needle core biopsy in the diagnosis of phyllodes neoplasm
Li et al. Shear wave elastography combined with gray-scale ultrasound for predicting central lymph node metastasis of papillary thyroid carcinoma
CN1675550A (zh) 基于溶液的检测方法
Stagner et al. p16 expression is not a surrogate marker for high-risk human papillomavirus infection in periocular sebaceous carcinoma
WO2022012289A1 (zh) 一种卵巢癌的外周血tcr标志物及其检测试剂盒和应用
Dziechciowski et al. Diagnostic and prognostic relevance of microparticles in peripheral and uterine blood of patients with endometrial cancer
US6569684B2 (en) Method of identifying and treating invasive carcinomas
JP5001859B2 (ja) 腫瘍診断方法
RU2613302C1 (ru) Способ определения продолжительности безрецидивного периода при серозном раке яичников
US20120028271A1 (en) Methods and Kit for Detecting Breast Cancer
Sulejmanovic et al. The value of fine-needle aspiration biopsy (FNAB) in differential diagnosis of scintigraphic cold thyroid nodule
WO2012088105A2 (en) Methods and compositions for predicting disease status in cancer
Yücel et al. The role of cervical elastography in the differential diagnosis of preinvasive and invasive lesions of the cervix
AU728286B2 (en) Detection of endometrial cancer
RU2812609C1 (ru) Способ прогнозирования риска раннего рецидива плоскоклеточного рака эндометрия у больных с I стадией заболевания
Hu et al. Shear wave elastography of invasive ductal carcinoma: correlations between shear wave velocity and histological prognostic factors
Nath et al. Cytomorphological scoring of breast lesions and its histopathological correlation
Marinaş et al. The study of p53 and p16 immunoexpression in serous borderline and malignant ovarian tumors
Zhou et al. Study on the correlation between different expression levels of Ki-67 and ultrasonic image characteristics in primary breast lymphoma
Almarzooqi et al. A rare and isolated presentation of primary cutaneous anaplastic large cell lymphoma on the breast
MXPA99008616A (en) Detection of endometrial cancer
Enache et al. Negative estrogen-receptor invasive breast carcinoma: mammographic aspects, correlations with HER2/neu oncoprotein status
Yıldırım The Role of Cervical Elastography in the Differential Diagnosis of Preinvasive and invasive Lesions of the Cervix

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication